Literature DB >> 24163734

Copper triflate-mediated synthesis of 1,3,5-triarylpyrazoles in [bmim][PF6] ionic liquid and evaluation of their anticancer activities.

V Kameshwara Rao1, Rakesh Tiwari, Bhupender S Chhikara, Amir Nasrolahi Shirazi, Keykavous Parang, Anil Kumar.   

Abstract

A simple, efficient, and environment friendly protocol for the synthesis of 1,3,5-triarylpyrazole and 1,3,5-triarylpyrazolines in [bimm][PF6] ionic liquid mediated by Cu(OTf)2 is described. The reaction protocol gave 1,3,5-triarylpyrazoles in good to high yields (71-84%) via a one-pot addition-cyclocondensation between chalcones and arylhydrazines, and oxidative aromatization without requirement for an additional oxidizing reagent. The catalyst can be reused up to four cycles without much loss in the catalytic activity. The pyrazoles (4a-o) and pyrazolines (3a-n) were evaluated for antiproliferative activity in SK-OV-3, HT-29, and HeLa human cancer cells lines. Among all compounds, 3b inhibited cell proliferation of HeLa cells by 80% at a concentration of 50 μM.

Entities:  

Year:  2013        PMID: 24163734      PMCID: PMC3806107          DOI: 10.1039/C3RA41830H

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  22 in total

Review 1.  Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

Authors:  V Craig Jordan
Journal:  J Med Chem       Date:  2003-03-27       Impact factor: 7.446

Review 2.  From 2000 to mid-2010: a fruitful decade for the synthesis of pyrazoles.

Authors:  Santos Fustero; María Sánchez-Roselló; Pablo Barrio; Antonio Simón-Fuentes
Journal:  Chem Rev       Date:  2011-08-01       Impact factor: 60.622

3.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

Authors:  S R Stauffer; C J Coletta; R Tedesco; G Nishiguchi; K Carlson; J Sun; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

4.  Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives.

Authors:  Zuhal Ozdemir; H Burak Kandilci; Bülent Gümüşel; Unsal Caliş; A Altan Bilgin
Journal:  Eur J Med Chem       Date:  2006-10-25       Impact factor: 6.514

5.  Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship.

Authors:  Jin Xie; Gennadiy I Poda; Yiding Hu; Natalie X Chen; Richard F Heier; Serge G Wolfson; Matthew T Reding; Patrick J Lennon; Ravi G Kurumbail; Shaun R Selness; Xiong Li; Nandini N Kishore; Cynthia D Sommers; Lori Christine; Sheri L Bonar; Neetu Venkatraman; Sumathy Mathialagan; Sarah J Brustkern; Horng-Chih Huang
Journal:  Bioorg Med Chem       Date:  2010-12-23       Impact factor: 3.641

6.  Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.

Authors:  Lin Yan; Pei Huo; John S Debenham; Christina B Madsen-Duggan; Julie Lao; Richard Z Chen; Jing Chen Xiao; Chun-Pyn Shen; D Sloan Stribling; Lauren P Shearman; Alison M Strack; Nancy Tsou; Richard G Ball; Junying Wang; Xinchun Tong; Thomas J Bateman; Vijay B G Reddy; Tung M Fong; Jeffrey J Hale
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

7.  Diaryl-dialkyl-substituted pyrazoles: regioselective synthesis and binding affinity for the estrogen receptor.

Authors:  Gisele A Nishiguchi; Alice L Rodriguez; John A Katzenellenbogen
Journal:  Bioorg Med Chem Lett       Date:  2002-03-25       Impact factor: 2.823

8.  Regioselective synthesis of 1,3,5-triaryl-4-alkylpyrazoles: novel ligands for the estrogen receptor.

Authors:  Y R Huang; J A Katzenellenbogen
Journal:  Org Lett       Date:  2000-09-07       Impact factor: 6.005

9.  Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.

Authors:  Anil Kumar; Israr Ahmad; Bhupender S Chhikara; Rakesh Tiwari; Deendayal Mandal; Keykavous Parang
Journal:  Bioorg Med Chem Lett       Date:  2011-01-15       Impact factor: 2.823

10.  Efficient routes to pyrazolo[3,4-b]indoles and pyrazolo[1,5-a]benzimidazoles via palladium- and copper-catalyzed intramolecular C-C and C-N bond formation.

Authors:  Sarvesh Kumar; Hiriyakkanavar Ila; Hiriyakkanavar Junjappa
Journal:  J Org Chem       Date:  2009-09-18       Impact factor: 4.354

View more
  5 in total

Review 1.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

Review 2.  Recent metal-catalysed approaches for the synthesis of cyclopenta[b]indoles.

Authors:  Thavaraj Vivekanand; Bishnupada Satpathi; Siddheshwar K Bankar; S S V Ramasastry
Journal:  RSC Adv       Date:  2018-05-22       Impact factor: 4.036

3.  Molecular iodine-catalyzed one-pot multicomponent synthesis of 5-amino-4-(arylselanyl)-1H-pyrazoles.

Authors:  Camila S Pires; Daniela H de Oliveira; Maria R B Pontel; Jean C Kazmierczak; Roberta Cargnelutti; Diego Alves; Raquel G Jacob; Ricardo F Schumacher
Journal:  Beilstein J Org Chem       Date:  2018-11-06       Impact factor: 2.883

Review 4.  The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of Relevant Applications.

Authors:  Sónia N Pedro; Carmen S R Freire; Armando J D Silvestre; Mara G Freire
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

5.  Continuous-flow synthesis of 3,5-disubstituted pyrazoles via sequential alkyne homocoupling and Cope-type hydroamination.

Authors:  Sándor B Ötvös; Ádám Georgiádes; Dániel Ozsvár; Ferenc Fülöp
Journal:  RSC Adv       Date:  2019-03-13       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.